14th February 2024

A group of researchers are investigating the efficacy of a new chemotherapy agent in achieving symptom relief in patients with palliative lung cancer.

A group of researchers are investigating the efficacy of a new chemotherapy agent in achieving symptom relief in patients with palliative lung cancer. 800 patients were recruited for the study, and half received the new medications. Fatal intracranial haemorrhage was noted in 50 patients who received the new medication compared to the 5 cases in the placebo group. 

What is the number needed to harm for the medication?